» Articles » PMID: 20838640

Dissecting the Relation Between a Nuclear Receptor and GATA: Binding Affinity Studies of Thyroid Hormone Receptor and GATA2 on TSHβ Promoter

Overview
Journal PLoS One
Date 2010 Sep 15
PMID 20838640
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Much is known about how genes regulated by nuclear receptors (NRs) are switched on in the presence of a ligand. However, the molecular mechanism for gene down-regulation by liganded NRs remains a conundrum. The interaction between two zinc-finger transcription factors, Nuclear Receptor and GATA, was described almost a decade ago as a strategy adopted by the cell to up- or down-regulate gene expression. More recently, cell-based assays have shown that the Zn-finger region of GATA2 (GATA2-Zf) has an important role in down-regulation of the thyrotropin gene (TSHβ) by liganded thyroid hormone receptor (TR).

Methodology/principal Findings: In an effort to better understand the mechanism that drives TSHβ down-regulation by a liganded TR and GATA2, we have carried out equilibrium binding assays using fluorescence anisotropy to study the interaction of recombinant TR and GATA2-Zf with regulatory elements present in the TSHβ promoter. Surprisingly, we observed that ligand (T3) weakens TR binding to a negative regulatory element (NRE) present in the TSHβ promoter. We also show that TR may interact with GATA2-Zf in the absence of ligand, but T3 is crucial for increasing the affinity of this complex for different GATA response elements (GATA-REs). Importantly, these results indicate that TR complex formation enhances DNA binding of the TR-GATA2 in a ligand-dependent manner.

Conclusions: Our findings extend previous results obtained in vivo, further improving our understanding of how liganded nuclear receptors down-regulate gene transcription, with the cooperative binding of transcription factors to DNA forming the core of this process.

Citing Articles

Thyroid hormone receptor β sumoylation is required for thyrotropin regulation and thyroid hormone production.

Ke S, Liu Y, Karthikraj R, Kannan K, Jiang J, Abe K JCI Insight. 2021; 6(16).

PMID: 34237030 PMC: 8410017. DOI: 10.1172/jci.insight.149425.


Protein Disulfide Isomerase Modulates the Activation of Thyroid Hormone Receptors.

Campos J, Doratioto T, Videira N, Ribeiro Filho H, Batista F, Fattori J Front Endocrinol (Lausanne). 2019; 9:784.

PMID: 30671024 PMC: 6331412. DOI: 10.3389/fendo.2018.00784.


RXR agonist modulates TR: corepressor dissociation upon 9-cis retinoic acid treatment.

Fattori J, Campos J, Doratioto T, Assis L, Vitorino M, Polikarpov I Mol Endocrinol. 2014; 29(2):258-73.

PMID: 25541638 PMC: 5414759. DOI: 10.1210/me.2014-1251.


Genome-wide binding patterns of thyroid hormone receptor beta.

Ayers S, Switnicki M, Angajala A, Lammel J, Arumanayagam A, Webb P PLoS One. 2014; 9(2):e81186.

PMID: 24558356 PMC: 3928038. DOI: 10.1371/journal.pone.0081186.


Negative regulation by nuclear receptors: a plethora of mechanisms.

Santos G, Fairall L, Schwabe J Trends Endocrinol Metab. 2011; 22(3):87-93.

PMID: 21196123 PMC: 3053446. DOI: 10.1016/j.tem.2010.11.004.

References
1.
Chandra V, Huang P, Hamuro Y, Raghuram S, Wang Y, Burris T . Structure of the intact PPAR-gamma-RXR- nuclear receptor complex on DNA. Nature. 2008; 456(7220):350-6. PMC: 2743566. DOI: 10.1038/nature07413. View

2.
Lonard D, OMalley B . SRC-3 transcription-coupled activation, degradation, and the ubiquitin clock: is there enough coactivator to go around in cells?. Sci Signal. 2008; 1(13):pe16. DOI: 10.1126/stke.113pe16. View

3.
Carr F, Wong N . Characteristics of a negative thyroid hormone response element. J Biol Chem. 1994; 269(6):4175-9. View

4.
Heck S, Bender K, Kullmann M, Gottlicher M, Herrlich P, Cato A . I kappaB alpha-independent downregulation of NF-kappaB activity by glucocorticoid receptor. EMBO J. 1997; 16(15):4698-707. PMC: 1170096. DOI: 10.1093/emboj/16.15.4698. View

5.
De Bosscher K, Vanden Berghe W, Haegeman G . Cross-talk between nuclear receptors and nuclear factor kappaB. Oncogene. 2006; 25(51):6868-86. DOI: 10.1038/sj.onc.1209935. View